Genvoya

Genvoya is a combination medication used in the treatment of HIV-1 infection. It contains four active ingredients: emtricitabine, tenofovir alafenamide, cobicistat, and elvitegravir. This oral medication is designed to help manage HIV by reducing the amount of virus in the body.

Genvoya is primarily used for the treatment of HIV-1 infection in adults and children who weigh at least 25 kg. This medication is part of a comprehensive treatment plan that includes other medications and lifestyle changes. Genvoya works by reducing the amount of HIV in the body, helping to control the progression of the disease. It is important to follow the advice of a healthcare provider when using Genvoya.

Common effects of Genvoya may include headache, nausea, and diarrhea. Some individuals may experience changes in body fat, such as increased fat in the upper back and neck, or loss of fat from the legs, arms, and face. It is important to discuss any persistent or severe side effects with a healthcare provider.

Genvoya should be used with caution in individuals with kidney or liver problems. It is important to inform a healthcare provider about any other medications being taken, as they may interact with Genvoya. Regular monitoring of kidney and liver function may be required during treatment. Pregnant women or those planning to become pregnant should consult a healthcare provider before using Genvoya.

Genvoya may interact with other medications, including those used to treat HIV, hepatitis C, and certain heart conditions. It is important to avoid taking Genvoya with medications that contain ritonavir or cobicistat, as this can increase the risk of side effects. Alcohol should be avoided while taking Genvoya, as it may worsen side effects. Always consult a healthcare provider before starting or stopping any medication.